Cogent Biosciences earnings were -$354.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest COGT earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$97.4M, down 5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, COGT reported annual earnings of -$328.9M, with 28.6% growth. The next COGT earnings date is Aug 4, 2026.
What were Cogent Biosciences's earnings last quarter?
On COGT's earnings call on May 12, 2026, Cogent Biosciences (NASDAQ: COGT) reported Q1 2026 earnings per share (EPS) of -$0.53, up 1.92% year over year. Total COGT earnings for the quarter were -$97.35 million. In the same quarter last year, Cogent Biosciences's earnings per share (EPS) was -$0.52.
The next COGT earnings call is Aug 4, 2026. Add COGT to your watchlist to be reminded of Cogent Biosciences's next earnings date.
Is Cogent Biosciences profitable or losing money?
As of the last Cogent Biosciences earnings report, Cogent Biosciences is currently losing money. Cogent Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$354.30 million, a 31.47% increase year over year.
What was COGT's earnings growth in the past year?
As of Cogent Biosciences's earnings date in May 12, 2026, Cogent Biosciences's earnings has grown year over year. COGT earnings in the past year totalled -$354.30 million.
What are Cogent Biosciences's earnings expectations?
The current EPS estimate for Cogent Biosciences's earnings report in Aug 4, 2026 is -$0.55.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.